| Code | 6475D | ||||||||||
| MA number | EU/1/20/1495/001 | ||||||||||
| Product Form: | plv cps 13 (2x0,5 mg+11x1 mg)x0,5 mg/1 mg (blis.PVC/PCTFE/Al) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| MAH, country: | STALLERGENES, France | ||||||||||
| Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 17.12.2020 |
| Validity: | 17.12.2025 |
| SmPC + PL: |
European Medicines Agency's database
|
| Safety feature | Yes |
| Data update: | 28.07.2021 |
